Page last updated: 2024-09-03

bay x 1005 and Myocardial Infarction

bay x 1005 has been researched along with Myocardial Infarction in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adalsteinsdottir, AE; Agnarsson, U; Andersen, K; Andresdottir, M; Arnar, DO; Bjornsdottir, H; Einarsson, A; Gottskalksson, G; Gudbjartsson, D; Gudmundsdottir, H; Gudmundsson, K; Gulcher, J; Gurney, M; Hakonarson, H; Hardarson, T; Helgadottir, A; Jonsson, A; Kong, A; Kristinsson, A; Kristjansson, K; Manolescu, A; Sigurdsson, A; Stefansson, K; Thorgeirsson, G; Thorvaldsson, S; Topol, EJ; Zink, F	1

Trials

1 trial(s) available for bay x 1005 and Myocardial Infarction

Article	Year
Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial. JAMA, 2005, May-11, Volume: 293, Issue:18 Topics: 5-Lipoxygenase-Activating Proteins; Aged; Biomarkers; Carrier Proteins; Coronary Artery Disease; Cross-Over Studies; Epoxide Hydrolases; Female; Humans; Leukotriene B4; Leukotriene E4; Lipoxygenase Inhibitors; Male; Membrane Proteins; Middle Aged; Myocardial Infarction; Peroxidase; Polymorphism, Single Nucleotide; Prospective Studies; Quinolines; Risk Factors	2005

Article

Year

Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial.

JAMA, 2005, May-11, Volume: 293, Issue:18

Topics: 5-Lipoxygenase-Activating Proteins; Aged; Biomarkers; Carrier Proteins; Coronary Artery Disease; Cross-Over Studies; Epoxide Hydrolases; Female; Humans; Leukotriene B4; Leukotriene E4; Lipoxygenase Inhibitors; Male; Membrane Proteins; Middle Aged; Myocardial Infarction; Peroxidase; Polymorphism, Single Nucleotide; Prospective Studies; Quinolines; Risk Factors

2005